A combination (I) of at least (a) an MC1-R receptor antagonist, (b) a tyrosinase inhibitor derived from vitamin C and (c) an inhibitor of the transport of melanocytes to keratinocytes. An independent claim is also included for a cosmetic and/or dermatological composition (II) containing combination (I) in a cosmetically- or dermatologically-acceptable vehicle.